Pennsylvania-based Inovio Pharmaceuticals Inc experienced a rise in share price following the company’s latest breakthrough regarding the development of its COVID-19 vaccine candidate.
As phase 1 test data showed, Inovio’s vaccine candidate, known as INO-4800, has been shown to be immunogenic in all test subjects. There was also no trace...
Chinese electric vehicle manufacturer XPeng made its first strides on the international stage by deciding to launch its vehicles in Norway. This marks the first occasion on which XPeng has attempted to conduct sales outside of China.
XPeng (XPEV) and its close local competitor Li Auto (LI) both completed their...
Moderna analyst Matthew Harrison predicts that his company’s stock prices will be heavily influenced by the FDA panel meeting that will take place on Thursday regarding the distribution of the biotech firm’s vaccine candidate.
Described by Harrison as “the most innovative vaccine developer” that is capable of outperforming the majority...
After weeks of friction between its chief executive officer and other key stakeholders, Volksgawen’s supervisory board resolved the extended conflict, endorsing CEO Herbert Diess in his role. As a result of this positive outcome, Volkswagen stocks incurred their largest rise in seven months.
The supervisory board sang Diess’ praises in...
With Monday’s COVID-19 vaccine rollout leading to the rise of riskier stocks, gold prices have suffered a minor decline, with spot gold falling by 0.4% to $1,831.75 per ounce. U.S. gold futures declined by 0.4% as well to a price of $1,836.80.
While news that a $908 billion U.S. COVID-19...
With the first rollout of the coronavirus vaccine and the approval of federal pandemic relief edging closer, a wave of optimism sharply drove up the value of U.S. stock futures on Monday. Across the ocean, Europe’s markets enjoyed a rally of their own, fueled by the hopes of an...
Pharmaceutical company AstraZeneca Plc has decided to make a move to purchase rare-disease specialist Alexion Pharmaceuticals Inc. for a hefty price tag of $39 billion. According to AstraZeneca, this move will account for the majority of the company’s growth, particularly following its low-return attempt at developing a COVID-19 vaccine...
With supply chain issues disrupting the manufacturing process, pharmaceutical company Pfizer has announced that the due date for the delivery of its COVID-19 vaccines has been slightly delayed.
In an interview with The Wall Street Journal, a spokesperson for Pfizer stated that it took longer than expected to scale the...
With online spending on Black Friday rising by 21.6% to $9 billion this year, Cyber Monday has been projected to be the biggest online shopping day to date. With sales estimates being projected to be anywhere between $10.8 billion and $12.7 billion, the NYSE has seen some major movements...
The majority of Middle Eastern stock markets enjoyed a modest rise as last week’s trading came to a close. This increase was largely fueled by rising crude oil prices as well as other gains in emerging markets.
Indexes across gulf nations Bahrain and Saudi Arabia, in addition to Abu Dhabi...